Analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright reissued a “buy” rating and set a $35.00 price objective on shares of SenesTech in a research report on Tuesday, May 14th.
Get Our Latest Research Report on SenesTech
SenesTech Stock Down 3.7 %
SenesTech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The company had revenue of $0.46 million for the quarter, compared to the consensus estimate of $0.49 million. During the same period last year, the firm posted ($84.03) EPS. Sell-side analysts anticipate that SenesTech will post -11 earnings per share for the current year.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in SenesTech stock. McAdam LLC bought a new position in SenesTech, Inc. (NASDAQ:SNES – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 5.19% of the company’s stock.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Stock Splits, Do They Really Impact Investors?
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- What is an Earnings Surprise?
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What Investors Need to Know About Upcoming IPOs
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.